Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients.

Statistical Methods for Rates and Proportions

2003 • 17,930 citations

Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2

1994 • 991 citations

Human tumor antigens recognized by T lymphocytes.

1996 • 860 citations

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.

1995 • 542 citations

Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

1994 • 467 citations

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

1995 • 446 citations

Promiscuous and allele-specific anchors in HLA-DR-binding peptides

1993 • 383 citations

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.

1995 • 310 citations

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.

1994 • 287 citations

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.

1996 • 259 citations

Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules

1994 • 234 citations

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

1995 • 213 citations

Induction of anti-self-immunity to cure cancer

1995 • 207 citations

Manipulation of costimulatory signals to enhance antitumor T-cell responses

1995 • 177 citations

Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation

1995 • 147 citations

Cytotoxic T Cells Isolated from Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu Proto-oncogene

1993 • 124 citations

MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

1994 • 98 citations

Primary proliferative T cell response to wild‐type p53 protein in patients with breast cancer

1995 • 98 citations

Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells.

1986 • 97 citations

Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif.

1992 • 85 citations

Multiple self epitopes on the Rhesus polypeptides stimulate immunologically ignorant human T cells in vitro

1994 • 73 citations

Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis

1993 • 72 citations

CD4+ T-cell immunity to mutated ras protein in pancreatic and colon cancer patients.

1995 • 63 citations

Motifs and supermotifs for MHC class II binding peptides.

1995 • 57 citations

HLA class II region nucleotide sequences.

1995 • 49 citations

An evaluation of the prognostic significance of HLA-DR expression in axillary-node-negative breast cancer.

1994 • 40 citations

Existent proliferative responses of peripheral blood mononuclear cells from healthy donors and ovarian cancer patients to HER-2 peptides.

1997 • 40 citations

Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70.

1994 • 38 citations

Attempts to Optimize Active Specific Immunotherapy for Melanoma

1991 • 28 citations